4 active not recruiting, 3 completed, 1 recruiting, 1 withdrawn. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow TScan Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation TSC-101, Control - AML, MDS | Phase 3 | Active not recruiting | TScan Therapeutics, Inc. | 310 | 2026-06-18 | 2026-10-05 |
| A Long Term Follow-up Study of TScan TCR-T Products Observational - AML, ALL | Recruiting | TScan Therapeutics, Inc. | 1000 | 2025-09-09 | 2025-09-10 | |
| A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors TSC-204-A0201, TSC-204-C0702, TSC-200-A0201 - Head and Neck Cancer, Cervical Cancer | Phase 1 | Active not recruiting | TScan Therapeutics, Inc. | 840 | 2024-05-06 | 2025-11-17 |
| A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors Tumor and HLA Profiling - Head and Neck Cancer, Cervical Cancer | Active not recruiting | TScan Therapeutics, Inc. | 1150 | 2023-06-26 | 2025-11-17 | |
| A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis | Completed | TScan Therapeutics, Inc. | 238 | 2023-01-03 | 2026-09-15 | |
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA) SOC + TSC-101, Control, SOC + TSC-100 - AML, MDS | Phase 1 | Active not recruiting | TScan Therapeutics, Inc. | 310 | 2022-11-01 | 2026-10-05 |
| A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. Tumor Biopsy - Solid Tumor, Adult | Completed | TScan Therapeutics, Inc. | 12 | 2021-02-26 | 2026-09-15 | |
| Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors Renal Clear Cell Carcinoma | Withdrawn | TScan Therapeutics, Inc. | 2020-12-17 | 2021-08-25 | ||
| Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection, Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types | Completed | TScan Therapeutics, Inc. | 80 | 2020-04-09 | 2021-04-14 |
Carcinoma, Renal Cell (2) · Head and Neck Neoplasms (2) · Melanoma (2) · Uterine Cervical Neoplasms (2) · Adenocarcinoma (1) · Autoimmune Diseases (1) · Birdshot Chorioretinopathy (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Celiac Disease (1) · Colitis, Ulcerative (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1) · Inflammatory Bowel Diseases (1)
Watchful Waiting (1)
United States (9)
Dawn Pinchasik, MD (2) · Shrikanta Chattopadhyay, MD (2) · James Hsieh, MD (1) · Michelle Matzko, MD (1)